Search research articles
Contact Us
Filters
Showing results (41-50 of 135) with videos related to
Page
of 14
Sort By:
Internal Medicine Journal
|
May 20, 2024
Therapeutic drug monitoring in anticancer agents: perspectives of Australian medical oncologists
Alexandra Flynn, Peter Galettis, Howard Gurney, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 18, 2019
Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and ∆(4)-abiraterone from cancer patients
Atul Bhatnagar, Matthew J McKay, Morten Thaysen-Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2018
Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment
Gerhardt Attard, Michael Borre, Howard Gurney, et al.
Cancer Chemotherapy and Pharmacology
|
July 2, 2017
Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring
Dhanusha Sabanathan, Alison Zhang, Peter Fox, et al.
Frontiers in Immunology
|
March 23, 2026
Distinct immunologic patterns of response and resistance to anti-PD-1/PD-L1-based immunotherapy in patients with soft tissue sarcoma
Brie-Anne Mannah, Fei Yang, Lijia Yu, et al.
Cancer Medicine
|
November 21, 2022
Five-year survival and clinical correlates among patients with advanced non-small cell lung cancer, melanoma and renal cell carcinoma treated with immune check-point inhibitors in Australian tertiary oncology centres
Lauren J Brown, Ines Pires da Silva, Tania Moujaber, et al.
The AAPS Journal
|
August 7, 2013
Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2
Fanfan Zhou, Jian Zheng, Ling Zhu, et al.
Endocrine Connections
|
March 24, 2022
Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients
Vita Birzniece, Teresa Lam, Mark McLean, et al.
BMJ Open
|
June 29, 2018
Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews
Marina T van Leeuwen, Steven Luu, Howard Gurney, et al.
Pharmacology Research & Perspectives
|
July 15, 2020
Nuances to precision dosing strategies of targeted cancer medicines
Ashley M Hopkins, Bradley D Menz, Michael D Wiese, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 135) with videos related to
Sort By:
Page
of 14
Internal Medicine Journal
|
May 20, 2024
Therapeutic drug monitoring in anticancer agents: perspectives of Australian medical oncologists
Alexandra Flynn, Peter Galettis, Howard Gurney, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
August 18, 2019
Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and ∆(4)-abiraterone from cancer patients
Atul Bhatnagar, Matthew J McKay, Morten Thaysen-Andersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2018
Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment
Gerhardt Attard, Michael Borre, Howard Gurney, et al.
Cancer Chemotherapy and Pharmacology
|
July 2, 2017
Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring
Dhanusha Sabanathan, Alison Zhang, Peter Fox, et al.
Frontiers in Immunology
|
March 23, 2026
Distinct immunologic patterns of response and resistance to anti-PD-1/PD-L1-based immunotherapy in patients with soft tissue sarcoma
Brie-Anne Mannah, Fei Yang, Lijia Yu, et al.
Cancer Medicine
|
November 21, 2022
Five-year survival and clinical correlates among patients with advanced non-small cell lung cancer, melanoma and renal cell carcinoma treated with immune check-point inhibitors in Australian tertiary oncology centres
Lauren J Brown, Ines Pires da Silva, Tania Moujaber, et al.
The AAPS Journal
|
August 7, 2013
Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2
Fanfan Zhou, Jian Zheng, Ling Zhu, et al.
Endocrine Connections
|
March 24, 2022
Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients
Vita Birzniece, Teresa Lam, Mark McLean, et al.
BMJ Open
|
June 29, 2018
Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews
Marina T van Leeuwen, Steven Luu, Howard Gurney, et al.
Pharmacology Research & Perspectives
|
July 15, 2020
Nuances to precision dosing strategies of targeted cancer medicines
Ashley M Hopkins, Bradley D Menz, Michael D Wiese, et al.
Page
of 14